EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Canagliflozin potentially promotes renal protection against glycerol-induced acute kidney injury by activating the AMPK/SIRT1/FOXO-3a/PGC-1α and Nrf2/HO-1 pathways

Abeer Bishr, Ahmed M Atwa, Bassant M El-Mokadem, Mahmoud Nour El-Din

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04017-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Abeer Bishr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt. abeer.bishr@acu.edu.eg. Hauptthemen laut MEDLINE: Acute Kidney Injury, Canagliflozin, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ahram Canadian University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The reno-protective potential of canagliflozin (Cana), an inhibitor of the sodium glucose–linked co-transporter-2 (SGLT-2), has been demonstrated in different models of kidney injury. However, its potential role in preventing glycerol (Gly)-induced acute kidney injury (AKI) remains to be divulged. Therefore, the aim of this study is to investigate the potential reno-protective effect of Cana and its underlying mechanism in a rat model of Gly-induced AKI. Rats were randomly allocated into five groups: normal, Gly, Gly pretreated with 10 mg/kg Cana, Gly pretreated with Cana 25 mg/kg, and normal pretreated with Cana 25 mg/kg for 14 consecutive days. Pretreatment with Cana improved renal structure and enhanced kidney functions manifested by reducing serum creatinine and blood urea nitrogen, as well as renal contents of neutrophil gelatinase-associated lipocalin and kidney injury molecule. Moreover, Cana signified its anti-inflammatory effect by reducing the Gly-induced elevation in renal contents of nuclear factor-κB and interleuκin-6. Additionally, Cana augmented the defense enzymatic antioxidants superoxide dismutase (SOD), manganese-SOD, and heme oxygenase-1, besides increasing the protein expression of the antioxidant transcription factor nuclear factor erythroid 2–related factor 2 to point for its ability to correct redox balance. Cana also upregulated the protein expression of the 5′ adenosine monophosphate-activated protein kinase (AMPK), Sirtuin1 (SIRT1), Forkhead box protein O3 (FOXO-3a), and peroxisome proliferator-activated receptor-gamma coactivator 1α (PGC-1α), as well as the transcriptional activity of growth arrest and DNA damage–inducible protein alpha (GAAD45a). In conclusion, Cana demonstrated potentially novel reno-protective mechanisms and mitigated the consequences of AKI through its antioxidant and anti-inflammatory properties, partially by activating the AMPK/SIRT1/FOXO-3a/PGC-1α pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryCanagliflozinSodium-Glucose Transporter 2 InhibitorsAnimalsSirtuin 1MaleNF-E2-Related Factor 2AMP-Activated Protein KinasesPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaGlycerolForkhead Box Protein O3KidneySignal TransductionRats, Sprague-DawleyRatsDisease Models, AnimalOxidative StressHeme Oxygenase (Decyclizing)

Stichwörter der Autor:innen

AMPK/SIRT1/FOXO-3aAcute kidney injuryCanagliflozinGlycerolNrf-2/HO-1PGC-1α

Substanzen

Sirtuin 1NF-E2-Related Factor 2AMP-Activated Protein KinasesPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaFOXO3 protein, ratCanagliflozinGlycerolPpargc1a protein, ratForkhead Box Protein O3Nfe2l2 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt. abeer.bishr@acu.edu.eg.
  • Department of Pharmacology and Toxicology, Egyptian Russian University, Cairo, Egypt.
  • College of Pharmacy, Al-Ayen Iraqi University, AUIQ, An Nasiriyah, Iraq.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Chinese University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Sadat City, Menoufia, Egypt.

Förderung

  • Ahram Canadian University

Zitieren

APA

Bishr, A., Atwa, A. M., El-Mokadem, B. M., & El-Din, M. N. (2025). Canagliflozin potentially promotes renal protection against glycerol-induced acute kidney injury by activating the AMPK/SIRT1/FOXO-3a/PGC-1α and Nrf2/HO-1 pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04017-x

Vancouver

Bishr A, Atwa AM, El-Mokadem BM, El-Din MN. Canagliflozin potentially promotes renal protection against glycerol-induced acute kidney injury by activating the AMPK/SIRT1/FOXO-3a/PGC-1α and Nrf2/HO-1 pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04017-x

BibTeX
@article{Bishr2025,
  author = {Bishr, Abeer and Atwa, Ahmed M and El-Mokadem, Bassant M and El-Din, Mahmoud Nour},
  title = {Canagliflozin potentially promotes renal protection against glycerol-induced acute kidney injury by activating the AMPK/SIRT1/FOXO-3a/PGC-1α and Nrf2/HO-1 pathways},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04017-x}
}
Kostenlos starten →